Metformin is typically the first medication doctors consider for insulin resistance, prediabetes with high risk features, and type 2 diabetes. It works primarily by reducing glucose production in the liver and modestly improving how cells respond to insulin. The National Institute of Diabetes and Digestive and Kidney Diseases highlights metformin’s long track record of safety and affordability, but it is not right for everyone — and it is not a substitute for lifestyle change.
How Metformin Works
Metformin is a biguanide. Its main mechanisms are:
- Decreasing hepatic glucose output: The liver makes less new glucose (gluconeogenesis), lowering fasting glucose.
- Improving peripheral insulin sensitivity: Muscle and fat tissue respond modestly better to insulin.
- Activating AMPK: An enzyme that helps regulate cellular energy and fat metabolism.
- Altering the gut microbiome: Emerging evidence suggests metformin changes gut bacteria in ways that may contribute to its glucose-lowering effect.
Unlike sulfonylureas, metformin does not directly stimulate insulin release from the pancreas, so it rarely causes hypoglycemia when used alone.
Who Might Benefit
Metformin is FDA-approved for type 2 diabetes. Clinicians also prescribe it off-label for:
- Prediabetes with very high A1C or multiple risk factors
- Polycystic ovary syndrome (PCOS) with insulin resistance
- Gestational diabetes (as an alternative or adjunct to insulin in some cases)
- Antipsychotic-associated weight gain
The American Diabetes Association suggests considering metformin for adults with prediabetes, particularly those under 60 with a BMI ≥ 35, those with a history of gestational diabetes, or those with rising A1C despite lifestyle changes. Learn more about prediabetes treatment options.
Evidence From the Diabetes Prevention Program
The Diabetes Prevention Program (DPP) — published in the New England Journal of Medicine in 2002 — randomized over 3,000 adults with prediabetes to lifestyle intervention, metformin, or placebo. Results over about three years:
| Group | Reduction in Type 2 Diabetes Incidence |
|---|---|
| Intensive lifestyle intervention | ~58% |
| Metformin | ~31% |
| Placebo | Reference |
Metformin was most effective in younger adults (under 60) and those with higher BMI. Lifestyle change outperformed metformin overall, which is why guidelines emphasize both.
Typical Dosing
Dosing is individualized, but common patterns include:
- Starting dose: 500 mg once daily with food
- Titration: Increase by 500 mg every 1–2 weeks as tolerated
- Typical effective dose: 1,500–2,000 mg per day, divided
- Maximum dose: 2,550 mg per day (immediate-release)
Extended-release metformin taken once daily often causes fewer stomach symptoms. Never change your dose without speaking to your clinician.
Side Effects
Most side effects are gastrointestinal — nausea, diarrhea, bloating, and metallic taste. These often fade within 1–2 weeks of starting or increasing a dose. Taking metformin with meals and using the extended-release form can help.
Less common but important:
- Vitamin B12 deficiency: Long-term use can lower B12. The ADA recommends periodic B12 screening.
- Lactic acidosis: A rare but serious risk, mostly in people with severe kidney disease, heart failure, or acute illness.
- Weight change: Often weight-neutral or associated with modest weight loss.
When Metformin Is Not Recommended
Metformin is generally avoided or dose-adjusted in:
- Severe kidney disease (eGFR below 30 mL/min/1.73 m²)
- Acute or unstable heart failure
- Liver disease with significant dysfunction
- History of lactic acidosis
- Severe alcohol use disorder
- Temporarily, around contrast imaging in people with reduced kidney function
Metformin and Lifestyle: Not Either-Or
Metformin works best alongside lifestyle change, not instead of it. The DPP’s lifestyle arm — emphasizing modest weight loss and 150 minutes of weekly activity — outperformed metformin. Combining both strategies likely offers additive benefits for many people.
For context on insulin resistance itself, see our prediabetes overview.
Metformin in PCOS and Fertility
Polycystic ovary syndrome is closely tied to insulin resistance. Metformin may improve menstrual regularity, modestly reduce androgen levels, and in some women, improve ovulation. It is not a first-line fertility treatment but is commonly used alongside standard care. Any off-label use should be discussed with a reproductive endocrinologist or gynecologist.
Monitoring on Metformin
Typical monitoring includes:
- A1C every 3–6 months until stable, then every 6 months
- Kidney function (eGFR, creatinine) at least annually
- Vitamin B12 periodically, especially after several years of use or with symptoms of deficiency
- Liver enzymes if clinically indicated
Common Questions
How Fast Does Metformin Work?
Fasting glucose often improves within a few days. A1C reflects about three months of glucose, so its full effect is typically seen at the next A1C check.
Can I Stop Metformin After My A1C Normalizes?
That decision is individual. Some people — particularly those who have lost significant weight and maintained lifestyle changes — can taper under medical supervision. Others benefit from continuing for long-term protection. Stopping without a plan can allow glucose to rise again.
Does Metformin Cause Hypoglycemia?
When used alone, hypoglycemia is uncommon. Risk rises if metformin is combined with insulin or sulfonylureas.
Does Metformin Interact With Alcohol?
Heavy or binge drinking increases the rare risk of lactic acidosis. Moderate alcohol is generally considered acceptable for most people on metformin; confirm with your clinician.
Emerging Research
Metformin is being studied for effects beyond glucose control, including potential roles in certain cancers, cardiovascular disease, and healthy aging. These uses remain investigational, and the FDA has not approved metformin for these indications. Interpret early results cautiously.
The Bottom Line
Metformin remains a first-line medication for insulin resistance and type 2 diabetes because of its effectiveness, safety record, and affordability. It lowers liver glucose production, modestly improves insulin sensitivity, and has good long-term evidence from trials like the Diabetes Prevention Program. Most side effects are mild and manageable with slow dose titration or extended-release tablets. Metformin works best combined with sustained lifestyle change — and decisions about starting, adjusting, or stopping it should always be made with your clinician, who can weigh kidney function, other conditions, and personal goals.
